John M. Capek's most recent trade in Abbott Laboratories was a trade of 6,247 Common shares without par value done at an average price of $99.8 . Disclosure was reported to the exchange on Feb. 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.77 per share. | 28 Feb 2023 | 6,247 | 339,443 (0%) | 0% | 99.8 | 623,263 | Common shares without par value |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 62,527 | 62,527 | - | - | Option (right to buy) | |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 15,855 | 345,690 (0%) | 0% | 0 | Common shares without par value | |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.41 per share. | 28 Feb 2022 | 7,086 | 329,835 (0%) | 0% | 122.4 | 867,397 | Common shares without par value |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 72,342 | 72,342 | - | - | Option (right to buy) | |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 15,523 | 336,921 (0%) | 0% | 0 | Common shares without par value | |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Sale of securities on an exchange or to another person at price $ 135.05 per share. | 13 Dec 2021 | 149,600 | 321,398 (0%) | 0% | 135.1 | 20,203,704 | Common shares without par value |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2021 | 149,600 | 0 | - | - | Option (right to buy) | |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.94 per share. | 13 Dec 2021 | 149,600 | 470,998 (0%) | 0% | 34.9 | 5,227,024 | Common shares without par value |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.58 per share. | 26 Feb 2021 | 9,267 | 321,398 (0%) | 0% | 121.6 | 1,126,682 | Common shares without par value |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 71,070 | 71,070 | - | - | Option (right to buy) | |
| Abbott | John M. Capek | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 13,865 | 330,665 (0%) | 0% | 0 | Common shares without par value | |
| Abbott | John M. Capek | Executive Vice President | Sale of securities on an exchange or to another person at price $ 111.86 per share. | 27 Aug 2020 | 52,300 | 316,800 (0%) | 0% | 111.9 | 5,850,278 | Common shares without par value |
| Abbott | John M. Capek | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2020 | 52,300 | 0 | - | - | Option (right to buy) | |
| Abbott | John M. Capek | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.03 per share. | 27 Aug 2020 | 52,300 | 369,100 (0%) | 0% | 27.0 | 1,413,857 | Common shares without par value |